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Demographic trends in the incidence of young-onset colorectal
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Background: Evidence is emerging that the incidence of colorectal cancer is increasing in young adults,
but the descriptive epidemiology required to better understand these trends is currently lacking.
Methods: A population-based cohort study was carried out including all adults aged 20–49 years diag-
nosed with colorectal cancer in England between 1974 and 2015. Data were extracted from the National
Cancer Registration and Analysis Service database using ICD-9/10 codes for colorectal cancer. Temporal
trends in age-specific incidence rates according to sex, anatomical subsite, index of multiple deprivation
quintile and geographical region were analysed using Joinpoint regression.
Results: A total of 56 134 new diagnoses of colorectal cancer were analysed. The most sustained
increase in incidence rate was in the group aged 20–29 years, which was mainly driven by a rise in distal
tumours. The magnitude of incident rate increases was similar in both sexes and across Index of Multiple
Deprivation quintiles, although the most pronounced increases in incidence occurred in the southern
regions of England.
Conclusion: Colorectal cancer should no longer be considered a disease of older people. Changes in
incidence rates should be used to inform future screening policy, preventative strategies and research
agendas, as well as increasing public understanding that younger people need to be aware of the symptoms
of colorectal cancer.
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Introduction
Colorectal cancer is a major cause of cancer-related mor-
tality and is the third most common cause of cancer death
in the UK1,2. Advances in the surgical and oncological
management of colorectal cancer are the most likely expla-
nation for the UK age-standardized mortality rate decreas-
ing from 49 to 27 per 100 000 person-years over the past
40 years2.
Despite age-standardized incidence rates remaining
static in the UK, as well as in other nations with a high
human development index3, there is increasing evidence
that incidence rates are increasing in adults aged less than
50 years. A US study4, using Surveillance, Epidemiology,
and End Results data, revealed a doubling in the incidence
rate of both colonic and rectal cancers among patients aged
between 20 and 54 years since 1974. Similar findings have
been demonstrated in cohorts from Canada5,6, Australia7,
New Zealand8 and, most recently, Europe9, suggesting
that the underlying risk of colorectal cancer is increasing
in young people.
Although men are well recognized to have a higher inci-
dence of colonic and rectal cancer in older age groups,
there is little difference in the incidence rates between
men and women aged less than 40 years10,11. UK data
have shown that men have a higher proportion of rec-
tal tumours, but that women have a higher proportion of
right-sided tumours12. However, data on anatomical sub-
site have not been linked to age-specific incidence trends
in the UK population. Data from North America4,6 sug-
gest that incidence rate increases have been driven by an
increase in distal tumours, whereas European data9 suggest
that incidence rate increases have been more pronounced
for colonic cancer.
© 2020 The Authors. BJS published by John Wiley & Sons Ltd on behalf of BJS Society Ltd. BJS 2020; 107: 595–605
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Socioeconomic status (SES) is associated with several
important colorectal cancer risk factors13–15. In the UK,
data from Northern Ireland16 have shown no difference
in age-standardized incidence between deprivation deciles,
unlike in Scotland, where men from more deprived areas
have an increased incidence of colorectal cancer with evi-
dence of an increasing deprivation gap over time17,18.
Previous studies have focused on SES as a risk factor for
colorectal cancer incidence, but this has never been anal-
ysed in the context of recent changes in age-specific inci-
dence trends in young adults. Significant variations in the
burden of disease exist between the nine regions of Eng-
land, including variation in the age-standardized rate of
years of life lost to colorectal cancer19,20. Understanding
whether there is a socioeconomic and regional variation in
incidence rate trends in the young population could help
elucidate potential aetiological factors.
Although data from the UK have been incorporated
in recent Europe-wide population-based studies9, a more
detailed description of the epidemiology underlying the
recent increase in colorectal cancer incidence in young
adults is required. This is vital, as young adults typically
present with more advanced tumours that carry a poorer
prognosis. A more thorough knowledge of the descrip-
tive epidemiology would help inform future preventative
strategies. Therefore, the aim of this study was to deter-
mine temporal trends in incidence of colorectal cancer
stratified by sex, anatomical subsite in the colorectum, SES
and geographical region of England.
Methods
This study is reported according to the STROBE guide-
lines for epidemiological studies21. Data were obtained
on all patients diagnosed with colorectal cancer aged
20 years and above from 1974 to 2015 using data from
the National Cancer Registration and Analysis Service
(NCRAS) (request ID: ODR1718_067). NCRAS is a
UK-wide partnership operated by Public Health England
to collect data on all types of cancer, including colorectal
cancer, occurring in the English population.
Procedures
ICD codes were used to identify all diagnoses of colorec-
tal cancer. ICD-9 codes (colon 153.0–153.9 (excluding
153.5 – appendiceal tumour); rectum 154.0 and 154.1) for
colorectal cancer were used for diagnoses made between
1974 and 1994. ICD-10 codes (colon C18.0–C18.9
(excluding C18.1 – appendiceal tumour); rectum C19
(rectosigmoid) or C20 (rectum)) were used for diagnoses
made between 1995 and 2015. Appendiceal adenocarci-
nomas were excluded and analysed separately (Fig. S1,
supporting information). For the purposes of this study,
young adults were defined as those aged 20–49 years, who
were divided into three groups based on age at diagnosis:
20–29, 30–39 and 40–49 years.
Mid-year population estimates were obtained from the
Office for National Statistics (ONS) to provide popula-
tion data stratified by age. Mid-year population estimates in
conjunction with the number of new diagnoses were used
to calculate age-specific incidence density rates per 100 000
person-years, referred to hereafter as the age-specific inci-
dence rates, for each age group using the following.
Age-specific incidence rate
=
No. of new cases in age group
Mid-year population estimate of age group
The European Standard Population 2013 (ESP 2013)
was then used to derive age-standardized incidence rates
for colonic and rectal cancer for the overall data set
(20–49 years), in accordance with the methodology for




(ESP of age group × age-specific rate)
∑
ESP of age group
Colorectal cancer cases were further stratified by sex
(using sex-specific population estimates from the ONS as
above), anatomical subsite (proximal – caecum to descend-
ing colon; distal – sigmoid to rectum), geographical region
(using region-based population estimates from the ONS
from 1981 onwards) and Index of Multiple Deprivation
(IMD) quintile (from 2001 onwards). IMD is an area-based
metric that combines weighted information from seven
domains: income (weighting 22⋅5 per cent), employment
(22⋅5 per cent), education (13⋅5 per cent), health (13⋅5 per
cent), crime (9⋅3 per cent), barriers to housing and ser-
vices (9⋅3 per cent) and living environment (9⋅3 per cent).
Lower-layer super output areas (LSOAs; 32 844 in Eng-
land) are given a value based on these domains. IMD quin-
tiles were calculated by ranking all LSOAs from most to
least deprived and then splitting this ranking into five equal
groups; each quintile has 20 per cent of the ranked areas.
Statistical analysis
Joinpoint Regression Program version 4.7.0.0 (Nati-
onal Cancer Institute; https://surveillance.cancer.gov/join
point/)23 was used to analyse the magnitude and direction
© 2020 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2020; 107: 595–605
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Age-specific incidence rates for men and women: a 20–29 years, b 30–39 years and c 40–49 years. Incidence rates per 100 000 are shown for each year; the
range of values plotted on the y-axis varies according to magnitude of incidence rate, to highlight trends. Plotted lines indicate annual percentage changes
(APCs). *Significant change in APC versus 0 (P < 0⋅050) using the permutation model of logarithmically transformed data.
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Age-specific incidence rates for proximal and distal tumours: a 20–29 years, b 30–39 years and c 40–49 years. Incidence rates per 100 000 are shown
for each year; the range of values plotted on the y-axis varies according to magnitude of incidence rate, to highlight trends. Plotted lines indicate annual
percentage changes (APCs). *Significant change in APC versus 0 (P < 0⋅050) using the permutation model of logarithmically transformed data. Data from
1974 to 1978 were excluded as it was not possible to map ICD-8 codes completely to later versions.
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of temporal trends in age-specific incidence rates accord-
ing to sex, anatomical site, IMD quintile and geographical
region. Permutation analysis of the log-transformed inci-
dence rates was used to fit a series of joined lines with a
minimum of 0 and a maximum of 5 join points. A series of
comparisons among fitted models ranging from 0 to 5 join
points was then undertaken to select the best-fit model.
This procedure allowed estimation of the annual percent-
age change (APC) in incidence. The squared correlation
coefficient (R2) was used to estimate the goodness of fit
of the Joinpoint regression models to provide an indica-
tion of the extent of agreement between modelled and
observed values. Inspection of residuals under the models
presented here did not give cause for concern; standard
errors appeared homoscedastic, free from serial correlation
and without any unduly influential observations.
Age–period–cohort modelling (National Cancer Insti-
tute; Age Period Cohort web tool; https://analysistools.nci
.nih.gov/apc) was used to assess the independent effects
of age, time period and cohort on colorectal cancer inci-
dence rates24. This was performed for all adults aged
over 20 years. Three 10-year age groups (20–29, 30–39
and 40–49 years for Joinpoint regression modelling) and
four 10-year periods (1976–1985, 1986–1995, 1996–2005,
2006–2015) were used for age–period–cohort modelling
as it was necessary to have age and time-period groups
covering an equal timespan. Therefore, there were 11
birth cohorts starting in 1886 through to 1986 in 10-year
bands. Reference values for the age–period–cohort model
were chosen arbitrarily from the first cohort analysed
(1976–1985). Data presented from this model were shown
as incidence rate ratios (IRRs) with 95 per cent confidence
intervals to assess cohort effects. Local drift was estimated
by examining age-specific net APC in incidence rates.
Results
Of the 1 145 639 new cases of colorectal cancer diagnosed
between 1974 and 2015 in adults aged over 20 years, there
were 2594 in 20–29 year olds, 11 406 among 30–39 year
olds and 42 134 in 40–49 year olds.
Age-specific trends according to sex
After an initial reduction in colorectal cancer incidence
rates, there was a marked increase in rates among both
20–29 and 30–39 year olds. In 20–29 year olds, incidence
rate increases commenced earlier in women (APC 4⋅6
(95 per cent c.i. 3⋅3 to 5⋅9) per cent from 1986) than in
men (APC 5⋅1 (3⋅7 to 6⋅5) per cent from 1992) (Fig. 1a).
In 30–39 year olds, incidence rate increases commenced a
decade later than in 20–29 year olds, with increases again
being observed earlier in women (APC 3⋅8 (2⋅9 to 4⋅8) per
cent from 1995) than in men (APC 6⋅0 (4⋅4 to 7⋅6) per
cent from 2002). The incidence rate trends observed in the
younger age groups were more attenuated in 40–49 year
olds, with small increases observed from 2003 onwards
in both women (APC 1⋅5 (0⋅5 to 2⋅5) per cent) and men
(APC 0⋅8 (–0⋅1 to 1⋅6) per cent) (Fig. 1c). These findings
were suggestive of an age cohort effect and assessed in
more detail using age–period–cohort modelling applied
to the entire adult population aged over 20 years. Using
the 1926 birth cohort as the reference group, the IRR
of colorectal cancer for cohorts born from 1886 to 1966
remained constant, following which there was a progressive
increase for successive birth cohorts (1976 cohort: IRR 1⋅4,
95 per cent c.i. 1⋅1 to 1⋅8; 1986 cohort: IRR 2⋅2, 1⋅3 to 3⋅8)
(Fig. S1b–k, supporting information).
Age-specific trends according to anatomical subsite
Increases in proximal cancer incidence rates were noted
in 20–29 year olds (APC 4⋅4 (95 per cent c.i. 2⋅3 to 6⋅5)
per cent from 1995) and 30–39 year olds (APC 5⋅8 (3⋅3 to
8⋅3) per cent from 2005), but with no observed effect in
40–49 year olds (APC 0⋅0 (–1⋅1 to 1⋅1) per cent from 2004)
(Fig. 2). The increase in age-standardized incidence rates
of proximal cancer among 20–49 year olds was predomi-
nantly driven by increases in the incidence of caecal and
ascending colon cancers (Fig. S2, supporting information).
Age-specific incidence rate increases in distal cancers
were more sustained and of greater magnitude than those
for proximal cancers among 20–29 year olds (APC 5⋅6 (4⋅4
to 6⋅8) per cent from 1991) and 30–39 year olds (APC 3⋅3
(1⋅0 to 5⋅7) per cent from 1995 to 2006; APC 7⋅0 (4⋅2 to
9⋅8) per cent from 2006). A less pronounced increase in
distal cancer was also noted among 40–49 year olds (APC
1⋅4 (0⋅7 to 2⋅1) per cent from 2001).
Age-standardized trends according
to socioeconomic status
The age-standardized incidence rates for distal cancers
increased more rapidly than those for proximal cancers in
all IMD quintiles, except quintile 2 (Fig. S3a–e, support-
ing information). There was no significant difference in
the magnitude of incidence rate increases across the quin-
tiles for either proximal (P = 0⋅110) or distal (P = 0⋅230)
cancers.
Age-standardized trends according to geographical
region
In 1985, age-standardized incidence rates of proximal can-
cers among 20–49 year olds were decreasing across all
© 2020 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2020; 107: 595–605
on behalf of BJS Society Ltd.
600 A. C. Chambers, S. W. Dixon, P. White, A. C. Williams, M. G. Thomas and D. E. Messenger
























































a  1985 b  1995











Annual percentage change (APC) in proximal colorectal cancer incidence rates calculated for each region of England using Joinpoint regression analysis:
a 1985, b 1995, c 2005 and d 2015. *Significant change in APC versus 0 (P < 0⋅050) using the permutation model of logarithmically transformed data.
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Annual percentage change (APC) in distal colorectal cancer incidence rates calculated for each region of England using Joinpoint regression analysis:
a 1985, b 1995, c 2005 and d 2015. *Significant change in APC versus 0 (P < 0⋅050) using the permutation model of logarithmically transformed data.
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regions of England, except in London, with the greatest
reduction observed in the South West (APC –12⋅1 (95 per
cent c.i. –20⋅3 to –3⋅1) per cent (Fig. 3). By 2015, incidence
rates were increasing fastest in the south-eastern regions
(South East: APC 7⋅4 (4⋅8 to 10⋅1) per cent; London: APC
6⋅5 (0⋅1 to 13⋅2) per cent; East: APC 6⋅0 (2⋅5 to 9⋅7) per
cent). A similar, but more pronounced, trend was noted
for distal cancers (Fig. 4). By 2005, the most rapid increase
in age-standardized incidence rates of distal cancer was
noted in the South West (APC 10⋅1 (6⋅1 to 14⋅1) per cent);
all other southern regions experienced annual increases of
more than 5 per cent.
Discussion
This large study based on a single, national population
registry describes detailed epidemiological changes in col-
orectal cancer incidence in a young adult population. The
finding that the incidence of colorectal cancer is increas-
ing rapidly in young adults supports recent findings from
other nations with a high human development index4–9,25.
Rapid increases were observed in adults aged 20–39 years,
which appear to be driven by increases in the rate of distal
tumours. Incidence rate increases in the English population
appear to be similar in both sexes and across all socioeco-
nomic groups. Importantly, incidence rates have increased
the fastest in the southern regions of England, particularly
in the South West, where the incidence of distal cancers
is now increasing by more than 10 per cent each year. A
substantial birth cohort effect was observed, with dramatic
increases in IRRs from the mid-1960s onwards. This is
similar to the observations in North American studies4,6,
although IRR increases in these studies appeared to have
occurred in birth cohorts born approximately 15 years ear-
lier. This suggests that any exposure to underlying risk
factors may have occurred earlier in the North American
population.
Tumours in young adults are thought to be sporadic26,
with environmental factors likely to play a significant
causative role. The rising incidence of colorectal can-
cer in young adults coincides with several environmental
changes, most notably increasing childhood and adult obe-
sity rates27. It is recognized that obesity in early life leads
to an increased risk of developing colorectal cancer28,29.
Therefore, the increases in colorectal cancer incidence in
young men and women may reflect the recent obesity
trends in the UK, where prevalence rates among adults
aged 35–54 years have increased from 15⋅4 to 26⋅3 per cent
in men, and from 17⋅9 to 24⋅5 per cent in women, between
1993 and 200430.
The more pronounced increase in the incidence rate
of distal compared with proximal tumours contrasts with
findings from recent European data9, but is similar to the
results from several North American studies4,6,31. Although
risk factors associated with an increased risk of colorec-
tal cancer have been identified, the strength of their asso-
ciation with tumour development at individual sites in
the colorectum remains unclear. Differences in the way
environmental factors promote tumorigenesis at various
sites in the colorectum suggest that proximal and distal
tumours may be biologically distinct entities32; this may
explain why the incidence in distal tumours among this
English cohort has increased more rapidly. The biologi-
cal differences in early- versus late-onset colorectal cancer
have been explored in several studies. A recent large cohort
study33,34 characterizing the clinical and molecular fea-
tures of early-onset colorectal cancer demonstrated enrich-
ment of certain phenotypes, such as consensus molecular
subtype 1 (CMS1) in distal tumours among adults aged
less than 50 years. Other work35,36 has shown low levels
of microsatellite instability in colorectal cancer in young
adults. Additionally, there is a prevalence of mutations in
genes such as β-catenin35,37 and KRAS38. Interestingly, the
combination of altered environmental exposures and dif-
ferent tumour biology suggests that young-adult colorectal
cancer may be a different disease from later-onset disease.
This study provided no evidence of an association
between SES and the rate of increase in incidence of
either proximal or distal tumours, in contrast to previous
studies16–18 where higher incidence rates were observed
in more deprived groups. Although factors associated with
an increased risk of colorectal cancer, such as obesity,
low-fibre diet and reduced physical activity, are known
to be associated with lower SES1–15, changes in obesity
prevalence trends are actually similar between socio-
economic groups39; this may partly explain the lack of
association between SES and colorectal cancer incidence
rate increases in the present study. Furthermore, obesity is
one of many risk factors associated with the development
of colorectal cancer, and is itself caused by several complex
societal, genetic and environmental interactions. It is
perhaps not surprising that understanding the causative
effects of single environmental risk factors is challenging40.
Geographical inequalities in health have been well
characterized in England. Incidence rates of all cancers
are higher in the north of England than in the south,
although there is minimal variation in colorectal cancer
incidence by region41. Recent incidence rate increases in
colorectal cancer were observed across all English regions
in the present study, although the most marked increases
occurred in the south. It is difficult to explain why inci-
dence rates are increasing more rapidly in young adults
in the south given that risk factors such as obesity are
© 2020 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2020; 107: 595–605
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increasing faster in northern regions39. It is important to
point out that the effect of regional variations in access
to healthcare/endoscopy services on colorectal cancer
incidence rates remains unknown, and it may be that the
incidence rate increases seen in the more affluent, south-
ern regions have been driven by increased awareness and
access to medical care.
The main strengths of this study are the size and com-
pleteness of the data set. Data were obtained from NCRAS,
a nationally curated cancer registry, with 100 per cent com-
plete data for 1974–2012 and 98⋅4 per cent complete data
for 2013–2015. Unfortunately, stage-specific data were
not recorded routinely until 2012, so further analysis of
incidence rate trends according to tumour stage was not
possible. It is important to know whether the increase
in young-onset colorectal cancer has been driven by an
increase in the detection of early-stage disease, particu-
larly in regions and socioeconomic groups that may have
increased health awareness and access to endoscopy ser-
vices. Data presented in this study are population-based
and specific causal inferences cannot be made. In addi-
tion, IMD quintile and geographical region are group-level
metrics and are unable to account for individual-level
contextual effects that could have affected the associa-
tion between these variables and colorectal cancer inci-
dence rates. Finally, endoscopy is being used increasingly
in England42, and it could be argued that this accounted for
the rising incidence of colorectal cancer. However, detec-
tion bias is unlikely as incidence rates were decreasing until
the 1990s, and the most rapid increases were noted in the
youngest age groups which are the least likely to attend for
endoscopic examination.
The incidence rate of young-onset colorectal cancer is
increasing, particularly among adults aged 20–39 years.
This trend appears to be predominantly driven by a rise in
distal tumours. Incidence rate increases of a similar mag-
nitude have been observed in both sexes and across IMD
quintiles, but are most pronounced in the south of Eng-
land. Importantly, there is a strong birth cohort effect and
it is likely that the increased risk in the youngest cohorts
will be carried forward as they age, which will place a sig-
nificant burden on future healthcare resources. The role
of environmental factors, such as diet, obesity, physical
exercise and the gut microbiota, in the development of
young-onset colorectal cancer is incompletely understood
and requires further research. Reducing the screening age
to below 50 years will have significant resource impli-
cations in the current economic climate43 and, instead,
there should be more focus on risk-stratifying symptomatic
younger patients to further investigation using tests such as
quantitative faecal immunohistochemical testing.
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